MURRAY DALLAN (Chief Customer Officer) sold 16.7% of their position (3.63K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $508.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/6/2024ACC: 0000950170-24-053837
Officer· Chief Customer Officer
Since Apr 2024
-3.63K
Net shares
Net seller
$508.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.63K
Price / share
$140.00
Trade value
$508.90K
% of position
16.7%
5/2/2024
21.76K→18.13K
Total
Net shares
−3.63K
Net value
-$508.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/2/2024 | S · Sale | −3.63K | $140.00 | $508.90K | 16.7% | 21.76K | 18.13K |
| Total | −3.63K | -$508.90K | ||||||
Derivative Transactions0
No derivative transactions reported